Toothbrushing in ICU may save you from hospital-acquired pneumonia
HQ Team December 20, 2023: Patients who brush their teeth may be saving themselves from hospital-acquired pneumonia and other outcomes, according to a.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team December 20, 2023: Patients who brush their teeth may be saving themselves from hospital-acquired pneumonia and other outcomes, according to a.
HQ Team December 19, 2023: An increase in Covid-19 cases across the world is causing concern. The surge is attributed to the detection.
By K. Leelamoni December 19, 2023: Recent reports about the FDA’s approval of gene therapy to treat Sickle Cell Anemia mark a major.
HQ Team, December 18, 2023: For individuals grappling with schizophrenia, the road to treatment is often marked by a lifelong commitment to antipsychotic.
HQ Team December 18, 2023: Investigative results from a pilot study showed that those with burnt-out diabetes and end-stage kidney disease experienced a.
HQ Team December 15, 2023: Teenagers are using e-cigarettes at a rate higher than adults, and in England, the numbers have tripled in.
HQ Team December 15, 2023: Merck announced it got USFDA approval for its belzutifan drug, branded as Welireg, to treat an advanced form.
HQ Team December 15, 2023: A new vaccine to aid the human body’s white cells to fight HIV infection may hold the key.
HQ Team December 13, 2023: Extracellular vesicles, or lipid particles released by human cells that cannot replicate, may serve as hidden reservoirs of.
HQ Team December 13, 2023: Vertex Pharmaceuticals, a US-based biotechnology company, announced its mid-stage trial on a non-opioid oral drug for patients with.